Comparative study to understand the clinically efficiency of Vigo Smart
Heart (VSH) against traditional holter in Indian Arrhythmia patients
Abstract
Arrhythmia is an irregular hertbeat which leads to severe heart
complications and it is the most common action of Cardio Vascular
Diseases. India represents 31% of global deaths and need for accurate
diagnosis and monitoring of Arrhythmia has not been addressed. In view,
we developed a novel device Vigo Holter (VSH) that is connected to cloud
and IoT based platform designed as an easy wearable for the patient. It
records continuous ECG and HR to predict the changes in the heart.
Compared a Vigo Holter against the traditional holter monitoring in 51
volunteers for 24 hrs with asymptomatic and symptomatic subjects. We
evaluated patient compliance, analyzable signal time interval to
arrhythmia detection, and diagnostic yield. In total 51 participants we
found 46 reports with equivalent result where as the conditions (Second
Degree Mobitz Type I block, First Degree AV block, IVCD and SVT
episodes) identified by VSH . Importantly, ECG wave quality in reports
with differences is same in both recordings and the total diagnostic
yield was 39%. Total Noise in Traditional Holter was 1301 minutes
whereas in Vigo Holter was 990 minutes. Total Analyzable time in Vigo
Holter was 99.3% whereas in Traditional Holter was 90.22%. VSH reports
clearly explained that no lead detachments and noise resultant from the
wire entanglements leading to low noise and highly analyzable time. We
demonstrated that VSH is very much needed and useful for people and
doctors to detect arrythmia with highest accuracy and to avoid physical
interaction with the patient during COVID-19